Calyx Bio-Ventures Inc (CVE: CYX)

CYX Technical Analysis

1.5

As on
9th Dec 2016 CYX Share Price closed @
0.08 and we RECOMMENDBuy
for LONG-TERM with Stoploss of
0.04 &
Sell for SHORT-TERM with Stoploss of
0.09
we also expect STOCK to react on Following IMPORTANT LEVELS.

Calyx Bio-Ventures Inc. owns a portfolio of patents related to modifying and engineering agricultural crop traits in Canada. Its technologies include Engineered Trait Loci (ETL) Technology that enhances crops; and REM technology. The company also holds rights to use the artificial chromosome expression (ACE) system for gene therapy and transgenics. In addition, it has interest in and licenses a technology to Agrisoma Biosciences Inc. that uses ETL technology to commercialize a suite of oil quality and crop improvement traits for use in energy feedstock crops. Calyx Bio-Ventures Inc. is headquartered in Vancouver, Canada.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
Your use of this website constitutes acceptance of our Terms Of Service